Bone health in children and adolescents with chronic diseases that may affect the skeleton: The 2013 ISCD pediatric official positions

Journal of Clinical Densitometry

Volumn 17, Issue 2, 2014, Pages 281-294

  Bianchi, Maria Luisa ^a   Leonard, Mary B ^b   Bechtold, Susanne ^c   Högler, Wolfgang ^d   Mughal, M Zulf ^e   Schönau, Eckhart ^f   Sylvester, Francisco A ^g   Vogiatzi, Maria ^h   van den Heuvel Eibrink, Marry M ⁱ   Ward, Leanne ^j  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^g Farmington   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^j CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

more..

Author keywords

Bone mineral density; Children; Chronic disease; DXA; Fractures

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADOLESCENT DISEASE; ANOREXIA NERVOSA; AREAL BONE MINERAL DENSITY; ARTICLE; BONE DENSITY; BONE DISEASE; BONE FRAGILITY; BONE MARROW TRANSPLANTATION; CELIAC DISEASE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; COMPRESSION FRACTURE; CROHN DISEASE; CYSTIC FIBROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; DUCHENNE MUSCULAR DYSTROPHY; FRAGILITY FRACTURE; GROWTH HORMONE DEFICIENCY; HEART TRANSPLANTATION; HIP DYSPLASIA; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; JOINT CONTRACTURE; JUVENILE OSTEOPOROSIS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCOLIOSIS; SICKLE CELL ANEMIA; THALASSEMIA; TURNER SYNDROME; ULCERATIVE COLITIS;

BONE MINERAL DENSITY; CHILDREN; CHRONIC DISEASE; DXA; FRACTURES;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; BONE DISEASES; BONE MARROW TRANSPLANTATION; CEREBRAL PALSY; CHILD; CHRONIC DISEASE; COLLAGEN TYPE I; ENDOCRINE SYSTEM DISEASES; FRACTURES, BONE; HUMANS; OSTEOGENESIS IMPERFECTA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84899923652     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2014.01.005     Document Type: Article

References (140)

1. Crabtree N.J., Arabi A., Bachrach L.K., et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom 2014, 17(2):225-242.
2. Leonard M.B., Propert K.J., Zemel B.S., et al. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr 1999, 135(2 Pt 1):182-188.
3. Zemel B.S., Kalkwarf H.J., Gilsanz V., et al. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 2011, 96(10):3160-3169.
4. Kalkwarf H.J., Gilsanz V., Lappe J.M., et al. Tracking of bone mass and density during childhood and adolescence. J Clin Endocrinol Metab 2010, 95(4):1690-1698.
5. Zemel B.S., Leonard M.B., Kelly A., et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010, 95(3):1265-1273.
6. Kalkwarf H.J., Zemel B.S., Gilsanz V., et al. The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 2007, 92(6):2087-2099.
7. Shepherd J.A., Fan B., Lu Y., et al. A multinational study to develop universal standardization of whole-body bone density and composition using GE Healthcare Lunar and Hologic DXA systems. J Bone Miner Res 2012, 27(10):2208-2216.
8. Zemel B.S., Stallings V.A., Leonard M.B., et al. Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery/Delphi dual-energy X-ray absorptiometry. J Clin Densitom 2009, 12(2):207-218.
9. Alos N., Grant R.M., Ramsay T., et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol 2012, 30(22):2760-2767.
10. Ben Amor I.M., Roughley P., Glorieux F.H., Rauch F. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res 2013, 28(9):2001-2007.
11. Halton J., Gaboury I., Grant R., et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 2009, 24(7):1326-1334.
12. Henderson R.C., Berglund L.M., May R., et al. The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy. J Bone Miner Res 2010, 25(3):520-526.
13. Tsampalieros A.K., Griffin L., Terpstra A.M., et al. Changes in DXA and quantitative CT measures of musculoskeletal outcomes following pediatric renal transplantation. Am J Transplant 2014, 14(1):124-132.
14. Burnham J.M., Shults J., Semeao E., et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 2004, 19(12):1961-1968.
15. Camurdan M.O., Ciaz P., Bideci A., Demirel F. Role of hemoglobin A(1c), duration and puberty on bone mineral density in diabetic children. Pediatr Int 2007, 49(5):645-651.
16. Misra M., Prabhakaran R., Miller K.K., et al. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab 2008, 93(4):1292-1297.
17. Coppola G., Fortunato D., Mainolfi C., et al. Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy. Epilepsia 2012, 53(12):2172-2177.
18. Bishop N., Braillon P., Burnham J., et al. Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008, 11(1):29-42.
19. Aglan M.S., Hosny L., El-Houssini R., et al. A scoring system for the assessment of clinical severity in osteogenesis imperfecta. J Child Orthop 2012, 6(1):29-35.
20. Minne H.W., Leidig G., Wuster C., et al. A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner 1988, 3(4):335-349.
21. Watanabe G., Kawaguchi S., Matsuyama T., Yamashita T. Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta. Spine (Phila Pa 1976) 2007, 32(17):E488-E494.
22. Rauch F., Lalic L., Roughley P., Glorieux F.H. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 2010, 25(6):1367-1374.
23. Ben Amor I.M., Glorieux F.H., Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos 2011, 2011:540178.
24. Bishop N., Adami S., Ahmed S.F., et al. Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet 2013, 382(9902):1424-1432.
25. Rauch F., Munns C.F., Land C., et al. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res 2009, 24(7):1282-1289.
26. Ward L.M., Rauch F., Whyte M.P., et al. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 2011, 96(2):355-364.
27. Antoniazzi F., Monti E., Venturi G., et al. GH in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol 2010, 163(3):479-487.
28. Pludowski P., Lebiedowski M., Olszaniecka M., et al. Idiopathic juvenile osteoporosis-an analysis of the muscle-bone relationship. Osteoporos Int 2006, 17(11):1681-1690.
29. Baroncelli G.I., Vierucci F., Bertelloni S., et al. Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients. J Bone Miner Metab 2013, 31(5):533-543.
30. Faje A.T., Fazeli P.K., Katzman D., et al. Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density. Clin Endocrinol (Oxf) 2013, 79(3):326-332.
31. Faje A.T., Fazeli P.K., Katzman D.K., et al. Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. Bone 2012, 51(3):474-479.
32. Misra M., Katzman D., Miller K.K., et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011, 26(10):2430-2438.
33. Divasta A.D., Feldman H.A., Giancaterino C., et al. The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism 2012, 61(7):1010-1020.
34. Divasta A.D., Feldman H.A., Gordon C.M. Vertebral fracture assessment in adolescents and young women with anorexia nervosa: a case series. J Clin Densitom 2014, 17(1):207-211.
35. Misra M., Prabhakaran R., Miller K.K., et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008, 93(4):1231-1237.
36. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 2007, 18(4):427-444.
37. Hamann C., Kirschner S., Gunther K.P., Hofbauer L.C. Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012, 8(5):297-305.
38. Brandao F.R., Vicente E.J., Daltro C.H., et al. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 2007, 78(3):334-339.
39. Bechtold S., Putzker S., Bonfig W., et al. Bone size normalizes with age in children and adolescents with type 1 diabetes. Diabetes Care 2007, 30(8):2046-2050.
40. Saha M.T., Sievanen H., Salo M.K., et al. Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos Int 2009, 20(8):1401-1406.
41. Abd El Dayem S.M., El-Shehaby A.M., Abd El Gafar A., et al. Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Invest 2011, 71(5):387-393.
42. Heilman K., Zilmer M., Zilmer K., Tillmann V. Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels. J Bone Miner Metab 2009, 27(5):598-604.
43. Diniz-Santos D.R., Brandao F., Adan L., et al. Bone mineralization in young patients with type 1 diabetes mellitus and screening-identified evidence of celiac disease. Dig Dis Sci 2008, 53(5):1240-1245.
44. Vestergaard P., Rejnmark L., Mosekilde L. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 2005, 77(3):139-144.
45. Vestergaard P., Weeke J., Hoeck H.C., et al. Fractures in patients with primary idiopathic hypothyroidism. Thyroid 2000, 10(4):335-340.
46. Salama H.M., El-Dayem S.A., Yousef H., et al. The effects of L-thyroxin replacement therapy on bone minerals and body composition in hypothyroid children. Arch Med Sci 2010, 6(3):407-413.
47. Demartini Ade A., Kulak C.A., Borba V.C., et al. Arq Bras Endocrinol Metabol 2007, 51(7):1084-1092.
48. Soucek O., Zapletalova J., Zemkova D., et al. Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. J Clin Endocrinol Metab 2013, 98(7):E1241-E1247.
49. Holroyd C.R., Davies J.H., Taylor P., et al. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome. Osteoporos Int 2010, 21(12):2093-2099.
50. Pitukcheewanont P., Numbenjapon N., Safani D., et al. Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy. Osteoporos Int 2011, 22(6):1709-1715.
51. Soucek O., Lebl J., Snajderova M., et al. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages. Clin Endocrinol (Oxf) 2011, 74(4):445-452.
52. Hansen S., Brixen K., Gravholt C.H. Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: a cross-sectional study using high-resolution-pQCT. J Bone Miner Res 2012, 27(8):1794-1803.
53. Hogler W., Briody J., Moore B., et al. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 2004, 89(1):193-199.
54. Nanao K., Tsuchiya Y., Kotoh S., Hasegawa Y. Low vertebral cancellous bone density in peripubertal girls with Turner's syndrome and boys with hypogonadism. J Pediatr Endocrinol Metab 2002, 15(9):1537-1542.
55. Sas T.C., de Muinck Keizer-Schrama S.M., Stijnen T., et al. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res 2001, 50(3):417-422.
56. Hogler W., Blimkie C.J., Cowell C.T., et al. Sex-specific developmental changes in muscle size and bone geometry at the femoral shaft. Bone 2008, 42(5):982-989.
57. Khastgir G., Studd J.W., Fox S.W., et al. A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome. J Bone Miner Res 2003, 18(5):925-932.
58. Neely E.K., Marcus R., Rosenfeld R.G., Bachrach L.K. Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 1993, 76(4):861-866.
59. Yap F., Hogler W., Briody J., et al. The skeletal phenotype of men with previous constitutional delay of puberty. J Clin Endocrinol Metab 2004, 89(9):4306-4311.
60. Hogler W., Shaw N. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol (Oxf) 2010, 72(3):281-289.
61. Bouillon R., Koledova E., Bezlepkina O., et al. Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 2004, 89(10):4993-4998.
62. Rosen T., Wilhelmsen L., Landin-Wilhelmsen K., et al. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997, 137(3):240-245.
63. Vestergaard P., Jorgensen J.O., Hagen C., et al. Fracture risk is increased in patients with GH deficiency or untreated prolactinomas-a case-control study. Clin Endocrinol (Oxf) 2002, 56(2):159-167.
64. Abs R., Mattsson A.F., Bengtsson B.A., et al. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Horm IGF Res 2005, 15(5):349-359.
65. Holmer H., Svensson J., Rylander L., et al. Fracture incidence in GH-deficient patients on complete hormone replacement including GH. J Bone Miner Res 2007, 22(12):1842-1850.
66. Wuster C., Abs R., Bengtsson B.A., et al. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001, 16(2):398-405.
67. Mazziotti G., Bianchi A., Bonadonna S., et al. Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res 2006, 21(4):520-528.
68. Fehlings D., Switzer L., Agarwal P., et al. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review. Dev Med Child Neurol 2012, 54(2):106-116.
69. Hough J.P., Boyd R.N., Keating J.L. Systematic review of interventions for low bone mineral density in children with cerebral palsy. Pediatrics 2010, 125(3):e670-e678.
70. Iwasaki T., Nonoda Y., Ishii M. Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis. Curr Med Res Opin 2012, 28(5):737-747.
71. Chen C.L., Chen C.Y., Liaw M.Y., et al. Efficacy of home-based virtual cycling training on bone mineral density in ambulatory children with cerebral palsy. Osteoporos Int 2013, 24(4):1399-1406.
72. Mergler S., Evenhuis H.M., Boot A.M., et al. Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review. Dev Med Child Neurol 2009, 51(10):773-778.
73. King W.M., Ruttencutter R., Nagaraja H.N., et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 2007, 68(19):1607-1613.
74. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010, 9(2):177-189.
75. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9(1):77-93.
76. Soderpalm A.C., Magnusson P., Ahlander A.C., et al. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord 2007, 17(11-12):919-928.
77. Mayo A.L., Craven B.C., McAdam L.C., Biggar W.D. Bone health in boys with Duchenne muscular dystrophy on long-term daily deflazacort therapy. Neuromuscul Disord 2012, 22(12):1040-1045.
78. Engkakul P., Mahachoklertwattana P., Jaovisidha S., et al. Unrecognized vertebral fractures in adolescents and young adults with thalassemia syndromes. J Pediatr Hematol Oncol 2013, 35(3):212-217.
79. Mirhosseini N.Z., Shahar S., Ghayour-Mobarhan M., et al. Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents. J Bone Miner Metab 2013, 31(4):468-476.
80. Fung E.B., Harmatz P.R., Milet M., et al. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone 2008, 43(1):162-168.
81. Vogiatzi M.G., Macklin E.A., Fung E.B., et al. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res 2009, 24(3):543-557.
82. Doulgeraki A., Athanasopoulou H., Voskaki I., et al. Bone health evaluation of children and adolescents with homozygous beta-thalassemia: implications for practice. J Pediatr Hematol Oncol 2012, 34(5):344-348.
83. Pirinccioglu A.G., Akpolat V., Koksal O., et al. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone 2011, 49(4):819-823.
84. Wong P., Fuller P.J., Gillespie M.T., et al. Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures. Osteoporos Int 2013, 24(7):1965-1971.
85. Sutipornpalangkul W., Janechetsadatham Y., Siritanaratkul N., Harnroongroj T. Prevalence of fractures among Thais with thalassaemia syndromes. Singapore Med J 2010, 51(10):817-821.
86. Vrijens B., Goetghebeur E. The impact of compliance in pharmacokinetic studies. Stat Methods Med Res 1999, 8(3):247-262.
87. Fung E.B., Kawchak D.A., Zemel B.S., et al. Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia. Pediatr Blood Cancer 2008, 50(3):620-623.
88. Meeuwes M., Souza de Carvalho T.F., Cipolotti R., et al. Bone mineral density, growth, pubertal development and other parameters in Brazilian children and young adults with sickle cell anaemia. Trop Med Int Health 2013, 18(12):1539-1546.
89. Garrido C., Cela E., Belendez C., et al. Status of vitamin D in children with sickle cell disease living in Madrid, Spain. Eur J Pediatr 2012, 171(12):1793-1798.
90. Hogler W., Wehl G., van Staa T., et al. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer 2007, 48(1):21-27.
91. Rayar M.S., Nayiager T., Webber C.E., et al. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2012, 59(1):77-82.
92. Mostoufi-Moab S., Brodsky J., Isaacoff E.J., et al. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab 2012, 97(10):3584-3592.
93. Paccou J., Zeboulon N., Combescure C., et al. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010, 86(1):1-7.
94. Papaioannou A., Kennedy C.C., Freitag A., et al. Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskelet Disord 2008, 9:125.
95. Hillman L.S., Cassidy J.T., Popescu M.F., et al. Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol 2008, 43(8):772-780.
96. Bianchi M.L., Colombo C., Assael B.M. Treatment of low bone density in young people with cystic fibrosis: a multicenter, prospective, open-label observational study of calcium and calcifediol followed by a randomized placebo-controlled trial of alendronate. Lancet Respir Med 2013, 1:377-385.
97. Cobanoglu N., Atasoy H., Ozcelik U., et al. Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis. Pediatr Pulmonol 2009, 44(7):706-712.
98. Douros K., Loukou I., Nicolaidou P., et al. Bone mass density and associated factors in cystic fibrosis patients of young age. J Paediatr Child Health 2008, 44(12):681-685.
99. Sermet-Gaudelus I., Souberbielle J.C., Ruiz J.C., et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007, 175(9):951-957.
100. Alicandro G., Bisogno A., Battezzati A., et al. Recurrent pulmonary exacerbations are associated with low fat free mass and low bone mineral density in young adults with cystic fibrosis. J Cyst Fibros 2013, [Epub ahead of print]. http://dx.doi.org/10.1016/j.jcf.2013.11001.
101. Rana M., Munns C.F., Selvadurai H., et al. The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis. Clin Endocrinol (Oxf) 2013, 78(1):36-42.
102. Madry E., Krasinska B., Drzymala-Czyz S., et al. Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients. Eur J Hum Genet 2012, 20(10):1092-1095.
103. Lucidi V., Bizzarri C., Alghisi F., et al. Bone and body composition analyzed by dual-energy X-ray absorptiometry (DXA) in clinical and nutritional evaluation of young patients with cystic fibrosis: a cross-sectional study. BMC Pediatr 2009, 9:61.
104. O'Reilly R., Fitzpatrick P., Leen G., et al. Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis. Ir Med J 2009, 102(2):47-49.
105. Kelly A., Schall J.I., Stallings V.A., Zemel B.S. Deficits in bone mineral content in children and adolescents with cystic fibrosis are related to height deficits. J Clin Densitom 2008, 11(4):581-589.
106. El-Matary W., Sikora S., Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 2011, 56(3):825-829.
107. Lopes L.H., Sdepanian V.L., Szejnfeld V.L., et al. Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease. Dig Dis Sci 2008, 53(10):2746-2753.
108. Schmidt S., Mellstrom D., Norjavaara E., et al. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden. Inflamm Bowel Dis 2009, 15(12):1844-1850.
109. Sylvester F.A., Wyzga N., Hyams J.S., et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(1):42-50.
110. Dubner S.E., Shults J., Baldassano R.N., et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 2009, 136(1):123-130.
111. Thayu M., Denson L.A., Shults J., et al. Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology 2010, 139(2):430-438.
112. Paganelli M., Albanese C., Borrelli O., et al. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(4):416-423.
113. Sbrocchi A.M., Forget S., Laforte D., et al. Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease. Pediatr Int 2010, 52(5):754-761.
114. Pappa H.M., Saslowsky T.M., Filip-Dhima R., et al. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. Am J Gastroenterol 2011, 106(8):1527-1543.
115. Semeao E.J., Stallings V.A., Peck S.N., Piccoli D.A. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology 1997, 112(5):1710-1713.
116. Kappelman M.D., Galanko J.A., Porter C.Q., Sandler R.S. Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 2011, 17(5):1125-1130.
117. Hill R.J., Brookes D.S., Davies P.S. Bones in pediatric Crohn's disease: a review of fracture risk in children and adults. Inflamm Bowel Dis 2011, 17(5):1223-1228.
118. Pappa H., Thayu M., Sylvester F., et al. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011, 53(1):11-25.
119. Ludvigsson J.F., Michaelsson K., Ekbom A., Montgomery S.M. Coeliac disease and the risk of fractures-a general population-based cohort study. Aliment Pharmacol Ther 2007, 25(3):273-285.
120. Olmos M., Antelo M., Vazquez H., et al. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 2008, 40(1):46-53.
121. Rodd C., Lang B., Ramsay T., et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) 2012, 64(1):122-131.
122. Wetzsteon R.J., Kalkwarf H.J., Shults J., et al. Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res 2011, 26(9):2235-2244.
123. Tsampalieros A., Kalkwarf H.J., Wetzsteon R.J., et al. Changes in bone structure and the muscle-bone unit in children with chronic kidney disease. Kidney Int 2013, 83(3):495-502.
124. Yenchek R.H., Ix J.H., Shlipak M.G., et al. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 2012, 7(7):1130-1136.
125. Iimori S., Mori Y., Akita W., et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study. Nephrol Dial Transplant 2012, 27(1):345-351.
126. Akaberi S., Simonsen O., Lindergard B., Nyberg G. Can DXA predict fractures in renal transplant patients?. Am J Transplant 2008, 8(12):2647-2651.
127. Bakr A.M. Bone mineral density and bone turnover markers in children with chronic renal failure. Pediatr Nephrol 2004, 19(12):1390-1393.
128. Waller S., Ridout D., Rees L. Bone mineral density in children with chronic renal failure. Pediatr Nephrol 2007, 22(1):121-127.
129. Griffin L.M., Kalkwarf H.J., Zemel B.S., et al. Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney disease. Pediatr Nephrol 2012, 27(7):1139-1148.
130. Helenius I., Remes V., Salminen S., et al. Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res 2006, 21(3):380-387.
131. Petryk A., Bergemann T.L., Polga K.M., et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006, 91(3):899-905.
132. Ruble K., Hayat M.J., Stewart K.J., Chen A.R. Bone mineral density after bone marrow transplantation in childhood: measurement and associations. Biol Blood Marrow Transplant 2010, 16(10):1451-1457.
133. Mostoufi-Moab S., Ginsberg J.P., Bunin N., et al. Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation. J Bone Mineral Res 2012, 27(4):760-769.
134. Mostoufi-Moab S., Ginsberg J.P., Bunin N., et al. Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr 2012, 160(1):122-128.
135. Kryskiewicz E., Pawlowska J., Pludowski P., et al. Bone metabolism in cholestatic children before and after living-related liver transplantation-a long-term prospective study. J Clin Densitom 2012, 15(2):233-240.
136. Pawlowska J., Matusik H., Socha P., et al. Beneficial effect of liver transplantation on bone mineral density in small infants with cholestasis. Transplant Proc 2004, 36(5):1479-1480.
137. D'Antiga L., Ballan D., Luisetto G., et al. Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation 2004, 78(6):899-903.
138. Okajima H., Shigeno C., Inomata Y., et al. Long-term effects of liver transplantation on bone mineral density in children with end-stage liver disease: a 2-year prospective study. Liver Transpl 2003, 9(4):360-364.
139. Valta H., Jalanko H., Holmberg C., et al. Impaired bone health in adolescents after liver transplantation. Am J Transplant 2008, 8(1):150-157.
140. Sachdeva R., Soora R., Bryant J.C., et al. Bone mineral status in pediatric heart transplant recipients: a retrospective observational study of an "at risk" cohort. Pediatr Transplant 2010, 14(3):383-387.